SHSonia Houssany-Pissot

Sonia Houssany-Pissot

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sonia Houssany-Pissot has a total of 43 co-authors. Here are the top co-authors by number of shared publications:

  • Alexandre Unger

    Université Paris Cité, Department of Cardiology, University Hospital of Lariboisiere, France (J.H., S.T., T.G., A.U., J.F., J.-G.D., T.P.).

    2 shared publications
  • Jean-Guillaume Dillinger

    Hôpital Lariboisière, (Assistance Publique des Hôpitaux de Paris, AP-HP), Cardiology department, Université Paris Cité , Paris

    2 shared publications
  • Jeremy Florence

    MIRACL.ai laboratory, Multimodality Imaging for Research and Analysis Core Laboratory-Artificial Intelligence, University Hospital of Lariboisiere (AP-HP), 75010, Paris, France

    2 shared publications
  • Nefissa Hamache

    MIRACL.ai laboratory, Multimodality Imaging for Research and Analysis Core Laboratory-Artificial Intelligence, University Hospital of Lariboisiere (AP-HP), 75010, Paris, France

    2 shared publications
  • Solenn Toupin

    MIRACL.ai laboratory, Multimodality Imaging for Research and Analysis Core Laboratory-Artificial Intelligence, University Hospital of Lariboisiere (AP-HP), 75010, Paris, France

    2 shared publications
  • Théo Pezel

    Hôpital Lariboisière, (Assistance Publique des Hôpitaux de Paris, AP-HP), Cardiology department, Université Paris Cité , Paris

    2 shared publications

Latest Publications

  • Long-term Prognostic Value of Stress Cardiovascular Magnetic Resonance in Patients with Hypertension without known coronary artery disease

    by Sonia Houssany-Pissot, Jérôme Garot, Suzanne Duhamel, Solenn Toupin, Alexandre Unger, Francesca Sanguineti, Stéphane Champagne, Thierry Unterseeh, Bernard Chevalier, Jeremy Florence, et al.

    AIM: Benefits of screening coronary artery disease (CAD) using stress perfusion cardiovascular magnetic resonance (CMR) in patients with hypertension without known CAD is not well established. The aim of our study was to assess the long-term prognostic value of vasodilator stress CMR in patients with hypertension without known CAD. METHODS: Between December 2008 and January 2022, all consecutive patients with hypertension without known CAD referred for stress CMR were followed up to the occurrence of major cardiovascular events (MACE), defined as cardiovascular mortality or non-fatal myocardial infarction (MI). Cox regressions were performed to determine the prognostic value of each parameter. RESULTS: Among 2,019 patients (69 ± 12 years; 45% male) with a median follow up of 6.7 (5.9- 8.9) years, 327 had MACE (16%). Patients without ischaemia experienced a lower rate of MACE than those with ischaemia (12 versus 39%, respectively, p < 0.001). Ischaemia and unrecognised MI were both significantly associated with the occurrence of MACE (respectively, HR: 4.1, 99.5%CI: 3.0-5.7 and HR: 3.6, 99.5%CI: 2.6-5.1, both p < 0.001). After adjustment, both the extent of ischaemia and unrecognised MI were independent predictors of MACE (respectively, HR: 1.2, 99.5%CI: 1.2-1.3, and HR: 1.2, 99.5%CI: 1.1-1.3, both p < 0.001). Adding stress CMR parameters improved model discrimination and reclassification, with greatest improvements in stepwise Model (C-statistic improvement: 0.02; net reclassification improvement: 0.50; integrative discrimination index: 0.02; all p < 0.001). CONCLUSION: In patients with hypertension without known CAD, stress CMR is a long-term predictor for the incidence of MACE and offer an incremental prognostic value over traditional predictors.

  • Open Access

    Prognostic Impact of Recreational Drug Use on 1-Year Outcomes in NSTEMI and STEMI Patients

    by Michael Aboujaoude, Nefissa Hamache, Jean Guillaume Dillinger, Antonin Trimaille, Claire Bouleti, Clément Delmas, Guillaume Schurtz, Sonia Houssany-Pissot, Reza Rossanaly Vasram, Guillaume Bonnet, et al.